August 24, 2018
Are Dangerous Drugs Making Their Way to the Market Via FDA Fast Track?
The drug Nuplazid made its way to the market by taking advantage of the Food and Drug Administration’s (FDA) “fast track” approval system known as “Breakthrough Therapy.” This system is designed to speed up the FDA approval process for new forms of treatment based on minimal clinical data. Nuplazid was granted the Breakthrough Therapy designation…
March 6, 2015
FDA Warns Testosterone Use Increases Heart Attack Risk
The U.S. Food and Drug Administration (FDA) is warning doctors against over-prescribing testosterone-boosting drugs for men saying that these popular treatments have not been established as a safe or effective means to improve common age-related issues such as low libido and fatigue. According to a report in The Wall Street Journal, the agency has said…